About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
BMC Medical Genomics
›
top-articles
BMC Medical Genomics
2.4
(top 20%)
impact factor
2.0K
(top 10%)
papers
39.6K
(top 10%)
citations
81
(top 10%)
h
-index
2.4
(top 20%)
impact factor
2.3K
all documents
44.1K
doc citations
124
(top 10%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
PrognoScan: a new database for meta-analysis of the prognostic value of genes
BMC Medical Genomics
2009
787
2
The eMERGE Network: A consortium of biorepositories linked to electronic medical records data for conducting genomic studies
BMC Medical Genomics
2011
618
3
The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis
BMC Medical Genomics
2008
425
4
Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases
BMC Medical Genomics
2009
421
5
From big data analysis to personalized medicine for all: challenges and opportunities
BMC Medical Genomics
2015
379
6
Development and verification of the PAM50-based Prosigna breast cancer gene signature assay
BMC Medical Genomics
2015
352
7
Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities
BMC Medical Genomics
2010
274
8
Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus
BMC Medical Genomics
2010
261
9
Exploring the oral microbiota of children at various developmental stages of their dentition in the relation to their oral health
BMC Medical Genomics
2011
259
10
PAM50 Breast Cancer Subtyping by RT-qPCR and Concordance with Standard Clinical Molecular Markers
BMC Medical Genomics
2012
250
11
EMT is the dominant program in human colon cancer
BMC Medical Genomics
2011
243
12
GENT2: an updated gene expression database for normal and tumor tissues
BMC Medical Genomics
2019
236
13
Optimally splitting cases for training and testing high dimensional classifiers
BMC Medical Genomics
2011
220
14
Molecular sampling of prostate cancer: a dilemma for predicting disease progression
BMC Medical Genomics
2010
219
15
Subtypes of primary colorectal tumors correlate with response to targeted treatment in colorectal cell lines
BMC Medical Genomics
2012
202
16
Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing
BMC Medical Genomics
2014
200
17
Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer
BMC Medical Genomics
2009
192
18
The IGNITE network: a model for genomic medicine implementation and research
BMC Medical Genomics
2015
189
19
Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells
BMC Medical Genomics
2009
187
20
Molecular genetics of human primary microcephaly: an overview
BMC Medical Genomics
2015
184
21
Gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age
BMC Medical Genomics
2008
181
22
Impact of RNA degradation on gene expression profiling
BMC Medical Genomics
2010
169
23
A genome-wide association study for late-onset Alzheimer's disease using DNA pooling
BMC Medical Genomics
2008
162
24
Multi-cancer computational analysis reveals invasion-associated variant of desmoplastic reaction involving INHBA, THBS2 and COL11A1
BMC Medical Genomics
2010
156
25
Targeted high throughput sequencing in clinical cancer Settings: formaldehyde fixed-paraffin embedded (FFPE) tumor tissues, input amount and tumor heterogeneity
BMC Medical Genomics
2011
154
26
Childhood abuse is associated with methylation of multiple loci in adult DNA
BMC Medical Genomics
2014
149
27
The role of the small intestine in the development of dietary fat-induced obesity and insulin resistance in C57BL/6J mice
BMC Medical Genomics
2008
147
28
Building prognostic models for breast cancer patients using clinical variables and hundreds of gene expression signatures
BMC Medical Genomics
2011
142
29
A high confidence, manually validated human blood plasma protein reference set
BMC Medical Genomics
2008
140
30
Deep RNA sequencing analysis of readthrough gene fusions in human prostate adenocarcinoma and reference samples
BMC Medical Genomics
2011
140
31
The removal of multiplicative, systematic bias allows integration of breast cancer gene expression datasets – improving meta-analysis and prediction of prognosis
BMC Medical Genomics
2008
134
32
Associations of circulating plasma microRNAs with age, body mass index and sex in a population-based study
BMC Medical Genomics
2015
133
33
Noninvasive Fetal Trisomy (NIFTY) test: an advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidies
BMC Medical Genomics
2012
132
34
Defining “mutation” and “polymorphism” in the era of personal genomics
BMC Medical Genomics
2015
129
35
A gene expression signature of RAS pathway dependence predicts response to PI3K and RAS pathway inhibitors and expands the population of RAS pathway activated tumors
BMC Medical Genomics
2010
124
36
miRNA signature associated with outcome of gastric cancer patients following chemotherapy
BMC Medical Genomics
2011
123
37
Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways
BMC Medical Genomics
2015
123
38
Predicting drug response of tumors from integrated genomic profiles by deep neural networks
BMC Medical Genomics
2019
123
39
Saliva samples are a viable alternative to blood samples as a source of DNA for high throughput genotyping
BMC Medical Genomics
2012
120
40
Discovering functional modules by identifying recurrent and mutually exclusive mutational patterns in tumors
BMC Medical Genomics
2011
119
41
Development of a blood-based gene expression algorithm for assessment of obstructive coronary artery disease in non-diabetic patients
BMC Medical Genomics
2011
117
42
Worldwide population differentiation at disease-associated SNPs
BMC Medical Genomics
2008
114
43
miR-10b-5p expression in Huntington’s disease brain relates to age of onset and the extent of striatal involvement
BMC Medical Genomics
2015
114
44
Whole genome identification of Mycobacterium tuberculosisvaccine candidates by comprehensive data mining and bioinformatic analyses
BMC Medical Genomics
2008
112
45
Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing
BMC Medical Genomics
2017
111
46
Evaluation of the bacterial diversity of Pressure ulcers using bTEFAP pyrosequencing
BMC Medical Genomics
2010
108
47
Batch effect correction for genome-wide methylation data with Illumina Infinium platform
BMC Medical Genomics
2011
108
48
FLAGS, frequently mutated genes in public exomes
BMC Medical Genomics
2014
108
49
High-resolution characterization of sequence signatures due to non-random cleavage of cell-free DNA
BMC Medical Genomics
2015
107
50
Systematic analysis, comparison, and integration of disease based human genetic association data and mouse genetic phenotypic information
BMC Medical Genomics
2010
106
site/software ©
exaly
; All materials licenced under
CC by-SA
.